Clarus (CLAR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual Meeting scheduled for May 29, 2025, will be held virtually; stockholders can vote online or by mail.
Key proposals include election of five directors, ratification of Deloitte & Touche LLP as auditor, and approval of an amended and restated 2015 Stock Incentive Plan.
Record date for voting is April 14, 2025; 38,401,824 shares outstanding and entitled to vote.
Proxy materials and annual report are available online; stockholders are encouraged to vote even if not attending.
Voting matters and shareholder proposals
Proposal 1: Elect five nominees to the Board of Directors for a one-year term.
Proposal 2: Ratify Deloitte & Touche LLP as independent auditor for 2025.
Proposal 3: Approve amended and restated 2015 Stock Incentive Plan, extending term by 10 years and reserving 7,500,000 shares.
Other business may be transacted as appropriate.
Board of directors and corporate governance
Board will be reduced from seven to five members after two directors resign at the meeting.
All nominees have significant experience in leadership, finance, law, engineering, and media.
Majority of directors are independent; lead independent director designated.
Board committees include Audit, Compensation, and Nominating/Corporate Governance, all with independent members.
Special Committee formed to review and approve the sale of the Precision Sport Segment.
Latest events from Clarus
- 2025 sales and margins fell, but 2026 guidance targets EBITDA growth and debt-free stability.CLAR
Q4 20255 Mar 2026 - Q2 sales fell, margins compressed, but cash surged and guidance was adjusted after asset sales.CLAR
Q2 20242 Feb 2026 - Q3 sales dropped 17.4%, losses widened, but gross margin and cash position improved.CLAR
Q3 202415 Jan 2026 - 2024 saw lower sales but improved margins and cash flow; 2025 outlook expects growth amid risks.CLAR
Q4 202418 Dec 2025 - Proxy supplement outlines major changes to the stock incentive plan and new proxy solicitor.CLAR
Proxy Filing1 Dec 2025 - Q1 sales dropped 13% and guidance was withdrawn amid macro and tariff uncertainty.CLAR
Q1 202521 Nov 2025 - Q2 sales fell 2%, net loss widened, and PIEPS divestiture advanced business simplification.CLAR
Q2 202516 Nov 2025 - Q3 sales up 3% to $69.3M, Adventure segment grew 16%, net loss narrowed to $1.6M.CLAR
Q3 202515 Nov 2025